CNTX
Context Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.36
+0.27 ▲ +8.74%
🌙 3월 13일 7:28 PM ET (한국 3/14 08:28)
$3.39
+0.03 ▲ +0.89%
| Index | - | P/E | - | EPS (ttm) | -0.28 | Insider Own | 29.26% | Shs Outstand | 0.09B | Perf Week | 7.69% |
| Market Cap | 0.31B | Forward P/E | - | EPS next Y | -21.52% | Insider Trans | - | Shs Float | 0.07B | Perf Month | 37.7% |
| Enterprise Value | 0.23B | PEG | - | EPS next Q | -0.1 | Inst Own | 53.22% | Short Float | 1.77% | Perf Quarter | 214.02% |
| Income | -0.03B | P/S | - | EPS this Y | 23.89% | Inst Trans | 4.44% | Short Ratio | 0.72 | Perf Half Y | 301.91% |
| Sales | 0.00B | P/B | 4.22 | EPS next 5Y | 4.76% | ROA | -31.94% | Short Interest | 1.15M | Perf YTD | 128.57% |
| Book/sh | 0.8 | P/C | 4.01 | EPS past 3/5Y | 11.27% 4.72% | ROE | -33.68% | 52W High | 1.82% ($3.30) | Perf Year | 414.08% |
| Cash/sh | 0.84 | P/FCF | - | Sales past 3/5Y | - | ROIC | -36.12% | 52W Low | 585.71% ($0.49) | Perf 3Y | 386.96% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 69.3% | Gross Margin | - | Volatility(W/M) | 10.82% 9.87% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.07 | EPS Q/Q | 53.07% | Profit Margin | - | RSI (14) | 72.76 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.07 | Sales Q/Q | - | SMA20 | 29.43% ($2.6) | Beta | 1.81 | Target Price | $5.67 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 52.53% ($2.2) | Rel Volume | 1.11 | Prev Close | $3.09 |
| Employees | 12 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -14.29% - | SMA200 | 169.37% ($1.25) | Avg Volume(3M) | 1.60M | Price | $3.36 |
| IPO | 2021/10/20 | Option/Short | No/Yes | Trades | 6570 | Volume | 1,771,115 | Change | 8.74% |
뉴스 로딩 중...